{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Imperial%20Palace%20Commodity%20-Dongguan-%20Co.%2C%20Ltd.","name":"Imperial Palace Commodity -Dongguan- Co., Ltd.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-06T01:48:31.004Z"},"count":1,"matches":[{"id":"4c69937113a03481","posted_date":"2025-02-04","letter_issue_date":"2025-01-27","company_name":"Imperial Palace Commodity -Dongguan- Co., Ltd.","issuing_office":"Center for Drug Evaluation and Research (CDER)","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/4c69937113a03481"}]}